Evidence map›Paper›PMID 40661539›Full record

ArticlebioRxiv : the preprint server for biology2025

Christopher Ashwood, Richard D Cummings

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Christopher AshwoodDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States.ORCID 0000-0001-5944-6179
Richard D CummingsDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States.ORCID 0000-0002-8918-5034

Funding

Protein-Glycan Interaction Resource at the National Center for Functional Glycomics (NCFG)R24GM137763 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI RICHARD D CUMMINGS · 2020 to 2026
$5.8M
Glycoproteomics and the Glycosylation Code of the Brain in Asymptomatic and Symptomatic Alzheimer’s DiseaseRF1AG062181 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CUMMINGS, RICHARD D, SEYFRIED, NICHOLAS THOMAS · 2018 to 2018
$4.1M
Engineering Escherichia coli for glycosylation of complex human proteinsR44GM088905 · NIGMS · GLYCOBIA, INC. · PI FISHER, ADAM CHARLES · 2011 to 2012
$1.6M
A Comprehensive 5K plus Glycan MicroarrayR43GM123820 · NIGMS · Z BIOTECH, LLC · PI ZHANG, JIAN · 2017 to 2018
$305k
Humanizing N-linked glycosylation in Escherichia coliR43GM088905 · NIGMS · GLYCOBIA, INC. · PI FISHER, ADAM CHARLES · 2009 to 2009
$116k
NIA NIH HHS RF1 AG062181NIGMS NIH HHS R24 GM137763NIGMS NIH HHS R43 GM088905NIGMS NIH HHS R43 GM123820NIGMS NIH HHS R44 GM088905NIH HHS HHSN272201400008C
6 · The paper itself

Abstract

Studies on glycans of glycoproteins are hampered by the lack of standards that reflect the wide diversity in structure typically observed. To this end we have exploited a large library of

Identifiers

PMID40661539
PMCPMC12259029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.